RAC1 and Miyoshi myopathy: RAC1 mRNA levels in purified BM plasma cells were significantly higher in patients with NDMM than in the controls, and high RAC1 mRNA expression in MM cells was associated with poor OS outcomes, regardless of ASCT, with a more pronounced effect in patients who underwent ASCT.